Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com
Bullboard Posts
User Avatar Image
(6)
•••
Comment by Lykitison Jun 09, 2014 2:57pm
222 Views
Post# 22643045

RE:RE:Tomorrow we gap up

RE:RE:Tomorrow we gap upGotta say... Finally a voice of reason here this morning, from JD. Folks, I paid 0.18-0.23 for this, some 2.5 years ago... wayyyy before the iDEAL study was a "thing". Waited patiently, and sold most of it earlier this year, but kept a little on the possibility of the iDEAL study results delivery explosive growth, followed by buyout. At this point though, I gotta agree with JD on this... commercial viability of ICO-007 is super doubtful now. ICO has other things going for it... but this ICO-007 horse in its stable is pretty much lame and not gonna run in any races anytime soon. I'm not experienced enough to venture a value on ICO as a whole... but imagining last week's .033 returning anytime soon is.... dreaming. My two cents... just another opinion among many.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities